2 years agoA Revenue Miss & Downbeat FY22 Outlook Was Saved By Johnson & Johnson's Pharmaceutical Segment AgainTicker Time News
1 year agoThe Top Five Highest Dividend Stock Picks for Investorslooking to Save Money and Grow Their Por...FineTimer
2 years agoMy New Forever Dividend Stock That is a Buy and Hold Forever REIT for Dividend Growth Investing 2022DarthDividend